• 1
    Stanghellini V, Corinaldesi R, Barbara L. Pseudo-obstruction syndromes. Baillieres Clin Gastroenterol 1988; 2: 22554.
  • 2
    Stanghellini V, Cogliandro RF, De Giorgio R et al.. Natural history of chronic idiopathic intestinal pseudo-obstruction in adults: a single center study. Clin Gastroent Hepatol 2005; 3: 44958.
  • 3
    Stanghellini V, Camilleri M, Malagelada JR. Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings. Gut 1987; 28: 512.
  • 4
    De Giorgio R, Camilleri M. Human enteric neuropathies: morphology and molecular pathology. Neurogastroenterol Motil 2004; 16: 51531.
  • 5
    De Giorgio R, Sarnelli G, Corinaldesi R, Stanghellini V. Advance in our understanding of the pathology of chronic intestinal pseudo-obstruction. Gut 2004; 53: 154952.
  • 6
    De Giorgio R, Seri M, Cogliandro R et al. Analysis of candidate genes for intrinsic neuropathy in a family with chronic idiopathic intestinal pseudo-Levine MS. Plain film diagnosis of the acute abdomen. Emerg Med Clin North Am 1985; 3: 54162.
  • 7
    Levine MS. Plain film diagnosis of the acute abdomen. Emerg Med Clin North Am 1985; 3: 54162.
  • 8
    Hayakawa K, Hamanaka Y, Suzuki M et al. Radiological findings in total colon aganglionosis and allied disorders. Radiat Med 2003; 21: 12834.
  • 9
    Simpson A, Sandeman D, Nixon S, Goulbourne I, Grieve D, Macintyre I. The value of an erect abdominal radiograph in the diagnosis of intestinal obstruction. Clin Radiol 1985; 36: 4142.
  • 10
    Murr M, Sarr M, Camilleri M. The surgeon's role in the treatment of chronic intestinal pseudo-obstruction. Am J Gastroent 1995; 90: 214751.
  • 11
    Cogliandro R, Stanghellini V, Cogliandro L et al.. Small Bowel manometric findings in different forms of severe digestive syndromes. Neurogastroenterol Motil 2004; 16: A838.
  • 12
    Malagelada JR, Stanghellini V. Manometric evaluation of functional upper gut symptoms. Gastroenterology 1985; 88: 122331.
  • 13
    Attar A, Kuoch V, Ducreux M, Benamouzig R, Malka D. Simultaneous decompression colonoscopy and radiologic G-tube insertion in a patient with megacolon because of chronic colonic pseudo-obstruction. Gastrointest Endosc 2005; 62: 9756.
  • 14
    Fell JME, Smith VV, Milla PJ. Infantile chronic idiopathic intestinal pseudo-obstruction: the role of small intestinal manometry as a diagnostic tool and prognostic indicator. Gut 1996; 39: 30611.
  • 15
    Kellow JE. Small intestine: normal function and clinical disorders. Manometry. In: SchusterMM, CrowellMD, KochKL, eds. Schuster Atlas of Gastrointestinal Motility in Health and Disease. Hamilton-London: BC Decker, 2002: 21936.
  • 16
    Camilleri M, Stanghellini V, Azpiroz F. Small bowel manometry. Dig Dis Sci 1997; 42: 24012.
  • 17
    Hyman PE, McDiarmid SV, Napolitano J, Abrams CE, Tomomasa T. Antroduodenal motility in children with chronic intestinal pseudo-obstruction. J Pediatr 1988; 112: 899905.
  • 18
    Hyman PE, Di Lorenzo C, Mc Adams L, Floers A, Tomomasa T, Garvey TQ. Predicting the clinical response to cisapride in children with chronic intestinal pseudo-obstruction. Am J Gastroenterol 1993; 88: 8326.
  • 19
    Boige N, Faure C, Cargill G et al.. Manometrical evaluation in visceral neuropathies in children. J Pediatr Gastroenterol Nutr 1994; 19: 717.
  • 20
    Cucchiara S, Annese V, Minella R et al.. Antroduodenojejunal manometry in the diagnosis of chronic idiopathic intestinal pseudoobstruction in children. J Pediatr Gastroenterol Nutr 1994; 18: 294305.
  • 21
    Di Lorenzo C, Flores AF, Buie T, Hyman PE. Intestinal motility and jejunal feeding in children with chronic intestinal pseudo-obstruction. Gastroenterology 1995; 108: 137985.
  • 22
    Heneyke S, Smith VV, Spitz L, Milla PJ. Chronic intestinal pseudo-obstruction: treatment and long-term follow-up of 44 patients. Arch Dis Child 1999; 81: 2127.
  • 23
    Mousa H, Hyman PE, Cocjin J, Flores AF, Di Lorenzo C. Long-term outcome of congenital intestinal pseudo-obstruction. Dig Dis Sci 2002; 47: 2298305.
  • 24
    Knowles CH, Silk DBA, Darzi A et al.. Deranged smooth muscle alpha-actin: a bio-marker of intestinal pseudo-obstruction. A controlled multinational case series. Gut 2004; 53: 15839.
  • 25
    De Giorgio R, Guerrini S, Barbara G et al.. Inflammatory neuropathies of enteric nervous system. Gastroenterology 2004; 126: 187283.
  • 26
    Mann SD, Debinski HS, Kamm MA. Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults. Gut 1997; 41: 67581.
  • 27
    Faure C, Goulet O, Ategbo S et al.. Chronic intestinal pseudoobstruction syndrome: clinical analysis, outcome and prognosis in 105 children. Dig Dis Sci 1999; 44: 9539.
  • 28
    Camilleri M, Balm RK, Zinsmeister AR. Determinant of response to a prokinetic agent in neuropathic chronic intestinal motility disorders. Gastroenterology 1994; 106: 91623.
  • 29
    Verne G, Eaker E, Hardy E, Sninsky C. Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction. Dig Dis Sci 1995; 40: 1892901.
  • 30
    Cogliandro R, Stanghellini V, Cogliandro L et al.. Symptomatic response to short-term treatment with cisapride but not small bowel manometry predicts a positive outcome in adult patients with chronic idiopathic intestinal pseudo-obstruction (CIIP). Gastroenterology 1999; 116: A1087.
  • 31
    Emmanuel AV, Shand AG, Kamm MA. Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. Aliment Pharmacol Ther 2004; 19: 68794.
  • 32
    Stanghellini V, Corinaldesi R, Ghidini C et al.. Reversibility of gastrointestinal motor abnormalities in chronic intestinal pseudo-obstruction. Hepatogastroenterology 1992; 39: 3438.
  • 33
    Pironi L, Spinucci G, Paganelli F et al.. Italian guidelines for intestinal transplantation: potential candidates among the adult patients managed by a medical referral center for chronic intestinal failure. Transplant Proc 2004; 36: 65961.
  • 34
    Barbara G, Stanghellini V, Brandi G et al.. Interactions between commensal bacteria and gut sensorymotor function in health and disease. Am J Gastroenterol 2005; 100: 25608.
    Direct Link:
  • 35
    Camilleri M, Malagelada JR, Abell TL, Brown ML, Hench V, Zinsmeister AR. Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudo-obstruction. Gastroenterology 1989; 96: 70412.
  • 36
    Di Lorenzo C, Reddy SN, Villanueva-Meyer J, Mena I, Martin S, Hyman PE. Cisapride in children with chronic intestinal pseudo-obstruction. An acute, double blind, crossover, placebo controlled trial. Gastroenterology 1991; 101: 156470.
  • 37
    Abell TL, Camilleri M, DiMagno EP, Hench VS, Zinsmeister AR, Malagelada JR. Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility. Dig Dis Sci 1991; 36: 61620.
  • 38
    Soudah HC, Hasler WL, Owyang C. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med 1991; 325: 14617.
  • 39
    Camilleri M, Balm RK, Zinsmeister AR. Symptomatic improvement with one-year cisapride treatment in neuropathic chronic dysmotility. Aliment Pharmacol Ther 1996; 10: 4039.
  • 40
    Masetti M, Di Benedetto F, Cautero N et al. Intestinal transplantation for chronic intestinal pseudo-obstruction in adult patients. Am J Transplantation 2004; 4: 8269.